Literature DB >> 25682378

Increasing the acceptance of internet-based mental health interventions in primary care patients with depressive symptoms. A randomized controlled trial.

D D Ebert1, M Berking2, P Cuijpers3, D Lehr4, M Pörtner2, H Baumeister5.   

Abstract

BACKGROUND: Internet-based interventions (IBI) are effective in treating depression. However, uptake rates in routine care are still limited. Hence, this study aimed to (1) assess the acceptance of IBIs in primary care patients with depressive symptoms and to (2) examine the effects of a brief acceptance facilitating intervention in the form of an informational video on patients' acceptance of IBIs.
METHODS: Primary care patients (N=128) with Minor or Major Depression were randomly assigned to an intervention (IG) or control group (CG). Patients in the IG were shown a brief informational video about IBIs before receiving a questionnaire that assessed their acceptance of IBIs and other secondary outcomes. Patients of the CG filled out the questionnaire immediately.
RESULTS: Baseline acceptance of IBIs in the CG was high for 6.3%, moderate for 53.1% and low for 40.6% of patients. Acceptance of IBIs was significantly higher in the IG when compared to the CG (d=.71, 95%-CI:.09-2.91). Except for social influence and the general attitude towards psychological treatment, all secondary outcomes were also significantly improved (e.g. effort- (d=.40) and performance-expectancy: d=.65; knowledge about Internet interventions d=.35). LIMITATIONS: Depression of the participants was only assessed using a self-report measure (PHQ-9).
CONCLUSION: Primary care patients' acceptance of IBIs for depressive symptoms was low but could be increased significantly using a brief acceptance facilitating intervention on the basis of an informational video. Future studies should further examine the potential of acceptance facilitating interventions for patients and health care providers to exploit the public health impact of IBIs.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acceptance; Depression; Implementation; Internet-based intervention; Randomized-controlled trial; e-health

Mesh:

Year:  2015        PMID: 25682378     DOI: 10.1016/j.jad.2015.01.056

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  72 in total

1.  An Internet-Based Intervention for Chronic Pain.

Authors:  Jiaxi Lin; Sarah Paganini; Lasse Sander; Marianne Lüking; David Daniel Ebert; Monica Buhrman; Gerhard Andersson; Harald Baumeister
Journal:  Dtsch Arztebl Int       Date:  2017-10-13       Impact factor: 5.594

2.  Acceptance and barriers to access of occupational e-mental health: cross-sectional findings from a health-risk population of employees.

Authors:  Severin Hennemann; Michael Witthöft; Matthias Bethge; Katja Spanier; Manfred E Beutel; Rüdiger Zwerenz
Journal:  Int Arch Occup Environ Health       Date:  2017-11-30       Impact factor: 3.015

3.  Barriers to Mental Health Service Use and Predictors of Treatment Drop Out: Racial/Ethnic Variation in a Population-Based Study.

Authors:  Jennifer Greif Green; Katie A McLaughlin; Mirko Fillbrunn; Marie Fukuda; James S Jackson; Ronald C Kessler; Ekaterina Sadikova; Nancy A Sampson; Corrie Vilsaint; David R Williams; Mario Cruz-Gonzalez; Margarita Alegría
Journal:  Adm Policy Ment Health       Date:  2020-07

4.  [Online therapy for depressive disorders : An acceptance-based analysis from the perspective of therapists].

Authors:  Christoph Dockweiler; Anna Kupitz; Sarah Palmdorf; Claudia Hornberg
Journal:  Nervenarzt       Date:  2020-03       Impact factor: 1.214

5.  Supporting People Who Have Lost a Close Person by Bereavement or Separation: Protocol of a Randomized Controlled Trial Comparing Two French-Language Internet-Based Interventions.

Authors:  Anik Debrot; Maya Kheyar; Liliane Efinger; Laurent Berthoud; Valentino Pomini
Journal:  JMIR Res Protoc       Date:  2022-06-23

6.  Increasing intentions to use mental health services among university students. Results of a pilot randomized controlled trial within the World Health Organization's World Mental Health International College Student Initiative.

Authors:  David Daniel Ebert; Marvin Franke; Fanny Kählke; Ann-Marie Küchler; Ronny Bruffaerts; Philippe Mortier; Eirini Karyotaki; Jordi Alonso; Pim Cuijpers; Matthias Berking; Randy P Auerbach; Ronald C Kessler; Harald Baumeister
Journal:  Int J Methods Psychiatr Res       Date:  2018-11-20       Impact factor: 4.035

Review 7.  Internet- Based Interventions in Chronic Somatic Disease.

Authors:  Eileen Bendig; Natalie Bauereiß; David Daniel Ebert; Frank Snoek; Gerhard Andersson; Harald Baumeister
Journal:  Dtsch Arztebl Int       Date:  2018-11-05       Impact factor: 5.594

8.  Clinical and Cost-Effectiveness of PSYCHOnlineTHERAPY: Study Protocol of a Multicenter Blended Outpatient Psychotherapy Cluster Randomized Controlled Trial for Patients With Depressive and Anxiety Disorders.

Authors:  Harald Baumeister; Natalie Bauereiss; Anna-Carlotta Zarski; Lina Braun; Claudia Buntrock; Christian Hoherz; Abdul Rahman Idrees; Robin Kraft; Pauline Meyer; Tran Bao Dat Nguyen; Rüdiger Pryss; Manfred Reichert; Theresa Sextl; Maria Steinhoff; Lena Stenzel; Lena Steubl; Yannik Terhorst; Ingrid Titzler; David Daniel Ebert
Journal:  Front Psychiatry       Date:  2021-05-14       Impact factor: 4.157

9.  ACTonDiabetes-a guided psychological internet intervention based on Acceptance and Commitment Therapy (ACT) for adults living with type 1 or 2 diabetes: results of a randomised controlled feasibility trial.

Authors:  Eileen Bendig; Natalie Bauereiss; Andreas Schmitt; Patrick Albus; Harald Baumeister
Journal:  BMJ Open       Date:  2021-07-09       Impact factor: 2.692

10.  Behavioral Intention to Use a Smartphone Usage Management Application Between a Non-Problematic Smartphone Use Group and a Problematic Use Group.

Authors:  Mun Joo Choi; Seo-Joon Lee; Sun Jung Lee; Mi Jung Rho; Dai-Jin Kim; In Young Choi
Journal:  Front Psychiatry       Date:  2021-06-17       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.